Release Date: 12/11/15 09:27 Summary: Appointment of New CEO and Executive Director Price Sensitive: Yes Download Document 77.98KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%